KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cvs Health (CVS) Invested Capital (2016 - 2025)

Cvs Health's Invested Capital history spans 17 years, with the latest figure at $139.8 billion for Q4 2025.

  • For the quarter ending Q4 2025, Invested Capital fell 1.56% year-over-year to $139.8 billion, compared with a TTM value of $139.8 billion through Dec 2025, down 1.56%, and an annual FY2025 reading of $139.8 billion, down 1.56% over the prior year.
  • Invested Capital for Q4 2025 was $139.8 billion at Cvs Health, up from $138.8 billion in the prior quarter.
  • The five-year high for Invested Capital was $142.0 billion in Q4 2024, with the low at $72.9 billion in Q3 2022.
  • Average Invested Capital over 5 years is $104.2 billion, with a median of $81.1 billion recorded in 2025.
  • Year-over-year, Invested Capital surged 87.27% in 2023 and then crashed 43.04% in 2025.
  • Tracing CVS's Invested Capital over 5 years: stood at $79.0 billion in 2021, then surged by 56.9% to $124.0 billion in 2022, then increased by 11.47% to $138.2 billion in 2023, then grew by 2.72% to $142.0 billion in 2024, then decreased by 1.56% to $139.8 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Invested Capital are $139.8 billion (Q4 2025), $138.8 billion (Q3 2025), and $80.6 billion (Q2 2025).